Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20534511 | 0.76 | LMNA (0.62) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL2552963 | 0.71 | CYP3A4 (0.57) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL23055551 | 0.70 | LMNA (0.69) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL11879018 | 0.70 | ATAD2 (0.52) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL31045621 | 0.69 | LMNA (0.54) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL31258082 | 0.69 | ALDH1A1 (0.62) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL2532353 | 0.68 | LMNA (0.53) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL2532356 | 0.68 | LMNA (0.53) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL2532358 | 0.68 | LMNA (0.53) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL13609115 | 0.68 | LMNA (0.56) | LMNAPOLBALDH1A1CYP1A2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644403-A1 | HALOGEN-CONTAINING COMPOUNDS USED FOR CAPPING THE 5' END OF NUCLEIC ACID AND USE THEREOF | Shenzhen Rhegen Biotechnology Co., Ltd. (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025082058-A1 | DSRNA THAT INHIBITS EXPRESSION OF LPA GENE AND USE THEREOF | 润佳(上海)医药技术有限公司 | 2025-04-24 | — | — | WO | disclosed |
| WO-2025082057-A1 | INHIBITOR FOR INHIBITING EXPRESSION OF INHIBIN BETA E GENE AND USE THEREOF | 润佳(上海)医药技术有限公司 | 2025-04-24 | — | — | WO | disclosed |